TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hyperphosphatemia (disorder)
|
0.480 |
Biomarker
|
disease |
HPO |
|
|
|
Calcinosis
|
0.430 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperostosis
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Angioid Streaks
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dental Enamel Hypoplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nephrocalcinosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Skin Abnormalities
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Taurodontism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Vascular calcification
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dental Pulp Stone
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased renal tubular phosphate excretion
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Conjunctival whitish salt-like deposits
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased renal tubular phosphate reabsorption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Subperiosteal bone formation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
CHARGE Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS shares several clinical and metabolic features with hyperphosphatemic familial tumoral calcinosis (HFTC), which is caused by mutations in GALNT3 encoding a glycosyltransferase responsible for initiating O-glycosylation.
|
15599692 |
2005 |
HOYERAAL-HREIDARSSON SYNDROME
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS shares several clinical and metabolic features with hyperphosphatemic familial tumoral calcinosis (HFTC), which is caused by mutations in GALNT3 encoding a glycosyltransferase responsible for initiating O-glycosylation.
|
15599692 |
2005 |
HYPOTRICHOSIS 1
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS shares several clinical and metabolic features with hyperphosphatemic familial tumoral calcinosis (HFTC), which is caused by mutations in GALNT3 encoding a glycosyltransferase responsible for initiating O-glycosylation.
|
15599692 |
2005 |
CHARGE Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS is caused by mutations in GALNT3, which encodes UDP-N-acetyl-alpha-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase 3.
|
17311862 |
2007 |
HOYERAAL-HREIDARSSON SYNDROME
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS is caused by mutations in GALNT3, which encodes UDP-N-acetyl-alpha-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase 3.
|
17311862 |
2007 |
HYPOTRICHOSIS 1
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HHS is caused by mutations in GALNT3, which encodes UDP-N-acetyl-alpha-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase 3.
|
17311862 |
2007 |
Hypotrichosis simplex
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hypotrichosis simplex (MIM 146520, HHS) is a rare form of nonsyndromic alopecia.
|
19751230 |
2010 |
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hyperostosis-hyperphosphatemia syndrome (HHS) is a rare autosomal recessive metabolic disorder caused by mutations in the GALNT3 and FGF23 genes.
|
25153226 |
2015 |
Hyperostosis-hyperphosphatemia syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Hyperostosis-hyperphosphatemia syndrome (HHS) is a rare autosomal recessive metabolic disorder caused by mutations in the GALNT3 and FGF23 genes.
|
25153226 |
2015 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
LHGDN |
GalNAc-T3 was positively detected in the majority of the cases of SCC, but not in dysplasia as well as the normal counterparts in resected esophagus.
|
15860931 |
2005 |